Smith & Nephew plc
NYSE:SNNMedical - Devices
-$0.43 today
- Market cap
- $12.72B
- Beta
- 0.67
- P/E (TTM)
- 20.1
- EPS (TTM)
- $0.74
- Dividend yield
- 2.59%
Volume 1.22M
Average 1.10M
SNN Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Smith & Nephew plcNYSE: SNN
Net Income · Q4 FY2025 · quarter ended Dec 2025
Net income grows 67.7% year over year
Q4 FY2025 net income of $332M rose 67.7% year over year. Over 3 fiscal years it compounded at +41.0% a year.
Context
- Net income amounted to 10.1% of revenue in FY2025, up 3.0 pp from a year earlier.
- Net income increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 7 analysts of $931.84M (+49.1%) for the fiscal year ending Dec 2026, a slowdown from the +51.7% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterDec 2025
- $332M— QoQ
- Last fiscal yearDec 2025
- $625M+51.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +67.7% | — | — |
| 1 year | +51.7% | +49.1% | -2.6 pp |
| 3-year CAGR | +41.0% | +21.4% | -19.6 pp |
| 5-year CAGR | +16.1% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 625M USD
- Year-over-year change
- +51.7%
- 4-year CAGR
- +4.5%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 625M | +51.7% |
| FY2024 | 2024-12-31 | 412M | +56.7% |
| FY2023 | 2023-12-31 | 263M | +17.9% |
| FY2022 | 2022-12-31 | 223M | -57.4% |
| FY2021 | 2021-12-31 | 524M | — |
Net Income vs competitors
How SNN compares with its peers on the latest reported figures
- SNN's FY2025 net income of $625M is the 4th largest of the 11 companies compared; the peer median is $18.93M.
- Its year-over-year change of +51.7% is the 3rd highest of 11, against a peer median of +26.1%.
- Net income amounts to 10.1% of revenue for SNN, versus a peer median of 16.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.73B | +27.8% | +11.2% | 14.4% | |
| LTM Apr 2026 | $1.12B | +38.5% | +365.2% | 49.1% | |
| LTM Jun 2026 | $808.5M | -2.0% | +34.3% | 9.5% | |
| FY2025 | $625M | +51.7% | +41.0% | 10.1% | |
| LTM Jun 2026 | $535.43M | +50.1% | +41.4% | 17.0% | |
| LTM Mar 2026 | $495.8M | +1612.2% | — | 30.1% | |
| LTM Mar 2026 | $178.05M | +24.5% | +67.1% | 21.6% | |
| LTM Mar 2026 | $125.36M | -24.3% | -1.8% | 15.9% | |
| LTM Mar 2026 | $54.85M | -53.8% | — | 4.0% | |
| LTM Mar 2026 | $39.68M | -2.5% | — | 16.3% | |
| LTM Mar 2026 | $1.83M | +115.2% | — | 1.5% | |
| Peer median (excluding SNN) | $18.93M | +26.1% | +37.9% | 16.1% | |
Competitors are the stored peer set for SNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 524M | 223M | 263M | 412M | 625M |
| Depreciation & Amortization | 563M | 548M | 527M | 555M | 573M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 41M | 40M | 39M | 40M | 43M |
| Change in Working Capital | (232M) | (510M) | (227M) | (123M) | 33M |
| Accounts Receivables | (81M) | (103M) | (49M) | (81M) | (175M) |
| Inventory | (151M) | (407M) | (178M) | (42M) | 208M |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | (19M) | 167M | 6M | 103M | 11M |
| Operating Cash Flow | 877M | 468M | 608M | 987M | 1.29B |
| Capital Expenditures | (408M) | (358M) | (427M) | (381M) | (433M) |
| Acquisitions (Net) | (285M) | (113M) | (21M) | (186M) | (9M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 2M | (1M) | 0 | (2M) | 36M |
| Investing Cash Flow | (691M) | (472M) | (448M) | (569M) | (406M) |
| Debt Repayment | (59M) | (43M) | (52M) | 945M | (140M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (158M) | 0 | 0 | (502M) |
| Dividends Paid | (329M) | (327M) | (327M) | (327M) | (330M) |
| Other Financing Activities | (257M) | (398M) | 179M | (704M) | 17M |
| Financing Cash Flow | (645M) | (926M) | (200M) | (86M) | (955M) |
| Effect of Forex Changes | (7M) | (11M) | (4M) | (15M) | 14.18M |
| Net Change in Cash | (466M) | (941M) | (44M) | 317M | (62M) |
| Free Cash Flow | 469M | 110M | 181M | 606M | 852M |
Smith & Nephew plc
NYSE:SNN
Intrinsic Alpha fair value
Locked
Current Price
$30.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.